DE69312579D1 - Arzneimittel zur Behandlung von Vulva-Dystrophie oder Vaginaltrockenheit - Google Patents

Arzneimittel zur Behandlung von Vulva-Dystrophie oder Vaginaltrockenheit

Info

Publication number
DE69312579D1
DE69312579D1 DE69312579T DE69312579T DE69312579D1 DE 69312579 D1 DE69312579 D1 DE 69312579D1 DE 69312579 T DE69312579 T DE 69312579T DE 69312579 T DE69312579 T DE 69312579T DE 69312579 D1 DE69312579 D1 DE 69312579D1
Authority
DE
Germany
Prior art keywords
medicines
vaginal dryness
vulvar dystrophy
treat vulvar
treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69312579T
Other languages
English (en)
Other versions
DE69312579T2 (de
Inventor
David Frederick Horrobin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Application granted granted Critical
Publication of DE69312579D1 publication Critical patent/DE69312579D1/de
Publication of DE69312579T2 publication Critical patent/DE69312579T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
DE69312579T 1992-05-27 1993-05-19 Arzneimittel zur Behandlung von Vulva-Dystrophie oder Vaginaltrockenheit Expired - Fee Related DE69312579T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929211229A GB9211229D0 (en) 1992-05-27 1992-05-27 Fatty acid treatment

Publications (2)

Publication Number Publication Date
DE69312579D1 true DE69312579D1 (de) 1997-09-04
DE69312579T2 DE69312579T2 (de) 1998-03-05

Family

ID=10716100

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69312579T Expired - Fee Related DE69312579T2 (de) 1992-05-27 1993-05-19 Arzneimittel zur Behandlung von Vulva-Dystrophie oder Vaginaltrockenheit

Country Status (15)

Country Link
US (1) US5380757A (de)
EP (1) EP0572159B1 (de)
JP (1) JPH0640903A (de)
AT (1) ATE156015T1 (de)
AU (1) AU660223B2 (de)
CA (1) CA2096556A1 (de)
DE (1) DE69312579T2 (de)
DK (1) DK0572159T3 (de)
ES (1) ES2107622T3 (de)
GB (1) GB9211229D0 (de)
GR (1) GR3025178T3 (de)
NO (1) NO931923L (de)
NZ (1) NZ247660A (de)
TW (1) TW336171B (de)
ZA (1) ZA933469B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ280017A (en) * 1994-09-21 1997-06-24 Scotia Holdings Plc Use of n-6 or n-3 series essential fatty acid (efa), and optionally an oestrogen, to make a medicament to treat or prevent hormone replacement therapy (hrt) associated breast pain in peri- or postmenopausal women; medicaments containing the efa and estrogen.
US5897880A (en) 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
US6387407B1 (en) 1995-09-29 2002-05-14 L.A.M. Pharmaceutical Corporation Topical drug preparations
US6251436B1 (en) 1995-09-29 2001-06-26 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
US6762202B2 (en) 2000-05-09 2004-07-13 Nitromed, Inc. Infrared thermography and methods of use
CA2417552C (en) 2000-06-27 2014-05-13 Qualilife Pharmaceuticals Inc. Compositions and methods for treating females sexual response
US20020172712A1 (en) * 2001-03-19 2002-11-21 Alan Drizen Antiemetic, anti-motion sustained release drug delivery system
US20030138494A1 (en) * 2001-05-15 2003-07-24 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US20030236284A1 (en) * 2002-06-14 2003-12-25 Alcon, Inc. Use of hydroxyeicosatetraenoic acid compounds to treat vaginal dryness
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
WO2006089348A1 (en) * 2005-01-20 2006-08-31 Kayban Pty Ltd Anti-microbial agent
EP2211881A4 (de) * 2007-11-01 2012-01-04 Wake Forest University School Of Medicine Zusammensetzungen und verfahren zur prävention und behandlung von krankheiten von säugetieren
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US20110159074A1 (en) * 2009-12-30 2011-06-30 Raphael Warren Wipe Article Comprising Lotion Composition Comprising Omega-6 Fatty Acid And Method Of Improving Skin Barrier Function
JP2013515778A (ja) * 2009-12-30 2013-05-09 ザ プロクター アンド ギャンブル カンパニー ω−６脂肪酸を含むローション組成物を含む拭き取り用物品
US20120083747A1 (en) * 2010-10-01 2012-04-05 Leo Galland Vaginal renewal complex and applicator
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
BR112016028518A2 (pt) 2014-06-04 2017-08-22 Dignity Sciences Ltd composições farmacêuticas que compreendem dgla e uso do mesmo

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU556817B2 (en) * 1982-02-03 1986-11-20 Efamol Limited Topical application of a lithium salt and dihomo-alpha- linolenic acid
US5145686A (en) * 1982-02-03 1992-09-08 Efamol Limited Topical pharmaceutical compositions
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
US5059622A (en) * 1989-08-29 1991-10-22 Biosyn, Inc. Method for reducing blood pressure levels in hypertensive persons
GB9116054D0 (en) * 1991-07-24 1991-09-11 Efamol Holdings Preparation of fatty acid medicaments

Also Published As

Publication number Publication date
DK0572159T3 (da) 1998-03-09
TW336171B (en) 1998-07-11
GB9211229D0 (en) 1992-07-08
NZ247660A (en) 1997-06-24
ES2107622T3 (es) 1997-12-01
DE69312579T2 (de) 1998-03-05
NO931923L (no) 1993-11-29
AU3861193A (en) 1993-12-02
JPH0640903A (ja) 1994-02-15
GR3025178T3 (en) 1998-02-27
EP0572159A1 (de) 1993-12-01
ATE156015T1 (de) 1997-08-15
US5380757A (en) 1995-01-10
CA2096556A1 (en) 1993-11-28
EP0572159B1 (de) 1997-07-30
AU660223B2 (en) 1995-06-15
ZA933469B (en) 1994-09-26
NO931923D0 (no) 1993-05-26

Similar Documents

Publication Publication Date Title
DE69312579D1 (de) Arzneimittel zur Behandlung von Vulva-Dystrophie oder Vaginaltrockenheit
HK37694A (en) Fatty acids compositions
FI893805A0 (fi) Fettsyrakomposition.
ATE89723T1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
NO940035D0 (no) Kolesterolester, samt anvendelse av slike estere
DE3875286T2 (de) Essentielle fettsaeure enthaltende zusammensetzungen.
ATE70183T1 (de) Topische zubereitungen mit gehalt an teer und fettsaeuren.
DE69005062T2 (de) Fettsäuren zur Behandlung und Prävention von Hautschäden durch Radiotherapie.
ATE19855T1 (de) Pharmazeutische und diaetetische zusammensetzung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee